 |
  |
|
Management
Team
david
m. geliebter
sven m. jacobson
Scientific
Advisory Board Members
critical
diagnostics advisory board members
james v. snider, Ph.D.,
president of critical diagnostics
james l. januzzi, md
robert l. jesse, md,
Ph.D.
richard
lee, md
alan stewart maisel,
md
david a. morrow, md,
mph
william franklin peacock
iv, md, facep
alan wu, Ph.D., D.A.B.C.C.
donna j. edmonds
remedy
pharmaceuticals' advisory board members
moses
v. chao, Ph.D.
gregory j. del zoppo,
md william dalton dietrich,
III, Ph.D.
ulrich dirnagl, md
edward d. hall, Ph.D.
j. marc simard, md, Ph.D.
eugene d. means, md (chief
medical officer)
|
|
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
| |
 |
Like any organization, people are the key to our success.
Carrot Capital Healthcare Ventures’ management team
draws upon this vast wealth of industry expertise and contacts
to identify investment opportunities, and to start businesses
around the technology and to nurture them into market leaders.
management
team
david
m. geliebter, managing partner
David is a serial entrepreneur with significant experience
successfully starting, growing and selling businesses. Prior
to starting Carrot Capital in 2001, David founded and ran
the Carson Group, one of the world’s most successful
financial information and advisory companies with over 450
employees and operations around the world. The company was
sold to Thomson Corporation for $200 million in cash. David
was also a founding principal and President of Evolution
Capital, a NASD broker/dealer subsidiary of Carson and an
early-stage and mezzanine level healthcare investment banking
firm. Before Carson Group, David started and ran another
successful business in the financial services sector: Harvard
Capital. This company was sold to WPP Group in 1986. He
was named Entrepreneur of the Year for New York in 1993
by Inc. magazine and Ernst & Young. David is also the
Chairman of Access Scientific and Remedy Pharmaceuticals, all Carrot Capital-initiated companies. He sits on the
boards of these companies.
next
>
|
 |
|
| |
 |
 |
 |
|
|
|